IVF Antagonist Protocol
Pre-clinicalUNKNOWN 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Polycystic Ovary Syndrome
Conditions
Polycystic Ovary Syndrome, Normal Volunteers
Trial Timeline
Dec 1, 2011 → Jan 1, 2014
NCT ID
NCT01487486About IVF Antagonist Protocol
IVF Antagonist Protocol is a pre-clinical stage product being developed by Merck for Polycystic Ovary Syndrome. The current trial status is unknown. This product is registered under clinical trial identifier NCT01487486. Target conditions include Polycystic Ovary Syndrome, Normal Volunteers.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01487486 | Pre-clinical | UNKNOWN |
Competing Products
20 competing products in Polycystic Ovary Syndrome